Definigen company
Our iPSC disease modeling services and platform will help you generate a range of metabolic and rare disease phenotypes for all your research needs!
Investors
%20.jpg)
%20.jpg)
Estimated Revenue:
$1M to $10M
Funding Status:
N/A
Industry:
Regenerative Medicine
Investors Number:
7
Number Of Exists:
Venture - Series Unknown
Technology:
Regenerative Medicine
Founded Date:
7-4
Investor Type:
Company
Headquarters:
Cambridge, UK
Total Funding:
£5.8M
Last Funding Type:
Venture - Series Unknown
Employee Number:
11-50
Investment Stage:
N/A